Deciphera Pharmaceuticals ticks higher as HSR waiting period for ONO sale expires

janiecbros/E+ via Getty Images Deciphera Pharmaceuticals ( NASDAQ: DCPH ) edged higher by 0.2% after the HSR period for its planned sale to ONO Pharmaceutical ( OTCPK:OPHLY ) expired. The HSR waiting period expired on Tuesday, according to a regulatory filing on Wednesday.

Late last month ONO Pharma ( OTCPK:OPHLY ) agreed to acquire all outstanding shares of Deciphera Pharma (DCPH ) for $25.60 per share in cash through a tender offer, resulting in an equity value of approximately $2.4 billion.

More on Deciphera Pharmaceuticals Diving Into Deciphera Pharmaceuticals ONO to acquire Deciphera Pharmaceuticals in $2.4B deal Deciphera stock soars after Ono Pharmaceutical’s $2.4B buyout deal Seeking Alpha’s Quant Rating on Deciphera Pharmaceuticals Historical earnings data for Deciphera Pharmaceuticals.